|
Neoplasia
Citations 131-140 of 4217 total displayed.
|
Past content
(since Jan 1997):
|
Analysis of clonotypic switch junctions reveals multiple myeloma originates from a single class switch event with ongoing mutation in the isotype-switched progeny
- Brian J. Taylor, Jitra Kriangkum, Julie A. Pittman, Michael J. Mant, Tony Reiman, Andrew R. Belch, and Linda M. Pilarski
Blood 2008; 112: 1894-1903.
[Abstract]
[Full text]
[PDF]
Dll4 activation of Notch signaling reduces tumor vascularity and inhibits tumor growth
- Marta Segarra, Cassin Kimmel Williams, Maria de la Luz Sierra, Marcelino Bernardo, Peter J. McCormick, Dragan Maric, Celeste Regino, Peter Choyke, and Giovanna Tosato
Blood 2008; 112: 1904-1911.
[Abstract]
[Full text]
[PDF]
Effective elimination of fludarabine-resistant CLL cells by PEITC through a redox-mediated mechanism
- Dunyaporn Trachootham, Hui Zhang, Wan Zhang, Li Feng, Min Du, Yan Zhou, Zhao Chen, Helene Pelicano, William Plunkett, William G. Wierda, Michael J. Keating, and Peng Huang
Blood 2008; 112: 1912-1922.
[Abstract]
[Full text]
[PDF]
Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia
- Laura Z. Rassenti, Sonia Jain, Michael J. Keating, William G. Wierda, Michael R. Grever, John C. Byrd, Neil E. Kay, Jennifer R. Brown, John G. Gribben, Donna S. Neuberg, Feng He, Andrew W. Greaves, Kanti R. Rai, and Thomas J. Kipps
Blood 2008; 112: 1923-1930.
[Abstract]
[Full text]
[PDF]
Biologic and genetic characterization of the novel amyloidogenic lambda light chain–secreting human cell lines, ALMC-1 and ALMC-2
- Bonnie K. Arendt, Marina Ramirez-Alvarado, Laura A. Sikkink, Jonathan J. Keats, Gregory J. Ahmann, Angela Dispenzieri, Rafael Fonseca, Rhett P. Ketterling, Ryan A. Knudson, Erin M. Mulvihill, Renee C. Tschumper, Xiaosheng Wu, Steven R. Zeldenrust, and Diane F. Jelinek
Blood 2008; 112: 1931-1941.
[Abstract]
[Full text]
[PDF]
Transcriptional repression of c-Myb and GATA-2 is involved in the biologic effects of C/EBP in p210BCR/ABL-expressing cells
- Angela Rachele Soliera, Maria Rosa Lidonnici, Giovanna Ferrari-Amorotti, Marco Prisco, Ying Zhang, Robert V. Martinez, Nick J. Donato, and Bruno Calabretta
Blood 2008; 112: 1942-1950.
[Abstract]
[Full text]
[PDF]
Sµ mutation patterns suggest different progression pathways in follicular lymphoma: early direct or late from FL progenitor cells
- Philippe Ruminy, Fabrice Jardin, Jean-Michel Picquenot, Françoise Parmentier, Nathalie Contentin, Gérard Buchonnet, Sandrine Tison, Vinciane Rainville, Hervé Tilly, and Christian Bastard
Blood 2008; 112: 1951-1959.
[Abstract]
[Full text]
[PDF]
Absence of SKP2 expression attenuates BCR-ABL–induced myeloproliferative disease
- Anupriya Agarwal, Thomas G. P. Bumm, Amie S. Corbin, Thomas O'Hare, Marc Loriaux, Jonathan VanDyke, Stephanie G. Willis, Jutta Deininger, Keiichi I. Nakayama, Brian J. Druker, and Michael W. Deininger
Blood 2008; 112: 1960-1970.
[Abstract]
[Full text]
[PDF]
Gossypol, a BH3 mimetic, induces apoptosis in chronic lymphocytic leukemia cells
- Kumudha Balakrishnan, William G. Wierda, Michael J. Keating, and Varsha Gandhi
Blood 2008; 112: 1971-1980.
[Abstract]
[Full text]
[PDF]
Id1 is a common downstream target of oncogenic tyrosine kinases in leukemic cells
- Winnie F. Tam, Ting-Lei Gu, Jing Chen, Benjamin H. Lee, Lars Bullinger, Stefan Fröhling, Andrew Wang, Stefano Monti, Todd R. Golub, and D. Gary Gilliland
Blood 2008; 112: 1981-1992.
[Abstract]
[Full text]
[PDF]
|
|
